A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau disease

J Med Genet. 2024 Oct 23;61(11):1026-1030. doi: 10.1136/jmg-2024-110202.

Abstract

von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the VHL tumour suppressor gene. VHL patients are at increased risk of developing multiple benign and malignant tumours. Current CLIA-based genetic tests demonstrate a very high detection rate of germline VHL variants in patients with clinical manifestations of VHL. In this report, we describe a large family with canonical VHL manifestations, for which no germline alteration had been detected by conventional germline testing. We identified a novel 291 kb chromosomal inversion involving chromosome 3p in affected family members. This inversion disrupts the VHL gene between exon 2 and exon 3 and is thereby responsible for the disease observed in this family.

Keywords: Chromosome Aberrations; Gene Rearrangement; Genetic Diseases, Inborn; Human Genetics; Urology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chromosome Inversion* / genetics
  • Chromosomes, Human, Pair 3* / genetics
  • Female
  • Genetic Predisposition to Disease
  • Germ-Line Mutation* / genetics
  • Humans
  • Male
  • Middle Aged
  • Pedigree*
  • Von Hippel-Lindau Tumor Suppressor Protein* / genetics
  • von Hippel-Lindau Disease* / complications
  • von Hippel-Lindau Disease* / genetics
  • von Hippel-Lindau Disease* / pathology

Substances

  • Von Hippel-Lindau Tumor Suppressor Protein
  • VHL protein, human